| Breast Hyperplasia studied in …STUDIED_INderived21 of 21show fewer |
|---|
| → studied in | NCT04570956Phase 2 · terminated Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk · condition mapped ONTOLOGY_EXACT · 21 trials mapped (7 active) | — | — | Breast Atypical Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06195306Phase 2 · recruiting Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction · condition mapped ONTOLOGY_EXACT · 21 trials mapped (7 active) | — | — | Breast Atypical Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06184750Phase 2 · recruiting Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial · condition mapped ONTOLOGY_EXACT · 21 trials mapped (7 active) | — | — | Breast Atypical Ductal Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05941520Phase 2 · recruiting Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer · condition mapped ONTOLOGY_EXACT · 21 trials mapped (7 active) | — | — | Breast Atypical Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05178498recruiting Impact of Dietary Inflammatory Potential on Breast Cancer Risk · condition mapped ONTOLOGY_EXACT · 21 trials mapped (7 active) | — | — | Breast Atypical Ductal Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05755269terminated Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women · condition mapped ONTOLOGY_EXACT · 21 trials mapped (7 active) | — | — | Breast Atypical Ductal Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01905046Phase 3 · active not recruiting Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer · condition mapped ALIAS · 21 trials mapped (7 active) | — | — | Breast Atypical Ductal Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02928978Phase 2 · completed Ruxolitinib for Premalignant Breast Disease · condition mapped ALIAS · 21 trials mapped (7 active) | — | — | Breast Atypical Lobular Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04496739NA · active not recruiting Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE) · condition mapped ALIAS · 21 trials mapped (7 active) | — | — | Breast Atypical Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07499999Phase 2 · not yet recruiting Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer · condition mapped ALIAS · 21 trials mapped (7 active) | — | — | Breast Atypical Lobular Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03868475NA · withdrawn Comparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast Lesions · condition mapped ALIAS · 21 trials mapped (7 active) | — | — | Breast Atypical Ductal Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05932758NA · unknown Excisional Vacuum-Assisted Breast Biopsy · condition mapped ALIAS · 21 trials mapped (7 active) | — | — | Breast Atypical Ductal Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05868252unknown Molecular Analysis of the Sloane Project · condition mapped ALIAS · 21 trials mapped (7 active) | — | — | Breast Atypical Ductal Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03323658Phase 1 · completed Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer · condition mapped ONTOLOGY_EXACT · 21 trials mapped (7 active) | — | — | Breast Atypical Ductal Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03505372NA · terminated Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia · condition mapped ALIAS · 21 trials mapped (7 active) | — | — | Breast Atypical Ductal Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01975363NA · completed Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer · condition mapped ALIAS · 21 trials mapped (7 active) | — | — | Breast Atypical Ductal Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01052740completed X-Ray Mammography Standard of Care Protocol · condition mapped ALIAS · 21 trials mapped (7 active) | — | — | Breast Atypical Ductal Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00637481Phase 1 · completed A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer · condition mapped ALIAS · 21 trials mapped (7 active) | — | — | Breast Atypical Ductal Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01372644Phase 1 · completed Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial · condition mapped ALIAS · 21 trials mapped (7 active) | — | — | Breast Atypical Ductal Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00620087NA · completed Molecular Breast Imaging in Women With Atypia and LCIS · condition mapped ALIAS · 21 trials mapped (7 active) | — | — | Breast Atypical Lobular Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01874184NA · completed Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer · condition mapped ALIAS · 21 trials mapped (7 active) | — | — | Breast Atypical Ductal Hyperplasia | 1 | Observed | clinicaltrials | graph → |